CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $36.73, but opened at $39.20. CochLear shares last traded at $39.20, with a volume of 455 shares traded.
Analyst Upgrades and Downgrades
CHEOY has been the topic of several research analyst reports. Zacks Research cut CochLear from a “hold” rating to a “strong sell” rating in a research note on Monday. UBS Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Thursday, April 23rd. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold”.
Get Our Latest Report on CHEOY
CochLear Price Performance
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More
- Five stocks we like better than CochLear
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
